The Use of Neuromuscular Blocking Agents in the ICU: Where Are We Now?

Intensivists use neuromuscular blocking agents for a variety of clinical conditions, including for emergency intubation, acute respiratory distress syndrome, status asthmaticus, elevated intracranial pressure, elevated intra-abdominal pressure, and therapeutic hypothermia after ventricular fibrillat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Critical care medicine 2013-05, Vol.41 (5), p.1332-1344
Hauptverfasser:	Greenberg, Steven B, Vender, Jeffery
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Critical Care - methods Critical Illness - therapy Evidence-Based Medicine Female Heart Arrest - drug therapy Humans Intensive care medicine Intensive Care Units Male Medical sciences Neuromuscular Blocking Agents - administration & dosage Neuromuscular Blocking Agents - adverse effects Prognosis Respiratory Distress Syndrome, Adult - drug therapy Risk Assessment Status Asthmaticus - drug therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!